Genetic
VGR-R01
VGR-R01 is a genetic therapy with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
GENETIC
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph early_phase_1
1
33%
Ph phase_1
1
33%
Ph phase_3
1
33%
Phase Distribution
2
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Early Phase 1First-in-human
1(33.3%)
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Active, not recruiting2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Early Phase 11 (33.3%)
Phase 11 (33.3%)
Phase 31 (33.3%)
Trials by Status
unknown133%
active_not_recruiting267%
Recent Activity
2 active trials
Showing 3 of 3
active_not_recruitingphase_1
Safety and Tolerability of VGR-R01 for Patients With Bietti Crystalline Dystrophy
NCT05694598
active_not_recruitingphase_3
Study to Evaluate the Efficacy and Safety of VGR-R01 Gene Therapy in Patients With Bietti Crystalline Dystrophy
NCT06699108
unknownearly_phase_1
Safety and Tolerability of VGR-R01 in Patients With Bietti Crystalline Dystrophy
NCT05399069
Clinical Trials (3)
Showing 3 of 3 trials
NCT05694598Phase 1
Safety and Tolerability of VGR-R01 for Patients With Bietti Crystalline Dystrophy
NCT06699108Phase 3
Study to Evaluate the Efficacy and Safety of VGR-R01 Gene Therapy in Patients With Bietti Crystalline Dystrophy
NCT05399069Early Phase 1
Safety and Tolerability of VGR-R01 in Patients With Bietti Crystalline Dystrophy
All 3 trials loaded
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 3